[Modeling cerebral dropsy (hydrocephalus) in animals by using angiotensin II]. 1978

N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina

The effect of a synthetic polypeptic hormone angiotensin-II on the structure of the brain ventricular system was studied in rats. A single injection of angiotensin-II, firm "Ciba", was given to rats in a dose of 0.05 mg/kg of body weight on the 1, 3, 7, 14 and 21st days. The brain was extirpated 15 min after the last injection, fixed in formalin and embedded in celloidin. Intact animals served as controls. A single injection of angiotensin-II was found to be accompanied by a slight dilatation of the brain lateral ventricles. Seven injections resulted in further accumulation of the fluid in the ventricles, and the first symptoms of the corpus callosum atrophy appeared. After the 21st injection of angiotensin-II a typical picture of hydrocephalus demonstrating further accumulation of the fluid in the brain ventricles was seen. The atrophic changes were especially pronounced in the corpus callosum, in white and grey substances of the frontal lobes of the cerebral hemispheres. Besides the atrophic changes, angiotensin-II-induced hydrocephalus resulted in subependymic edema, exfoliation of ependymal cells--the features characteristic for other types of hydrocephalus. Thus, injections of the synthetic hormone angiotensin-II can facilitate in producing an experimental atraumatic hydrocephalus. By means of angiotensin-II a desirable degree of hydrocephalus can be obtained by changing the dose of the preparation.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006849 Hydrocephalus Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA. Communicating Hydrocephalus,Congenital Hydrocephalus,Obstructive Hydrocephalus,Post-Traumatic Hydrocephalus,Aqueductal Stenosis,Cerebral Ventriculomegaly,Fetal Cerebral Ventriculomegaly,Hydrocephalus Ex-Vacuo,Hydrocephaly,Aqueductal Stenoses,Cerebral Ventriculomegalies,Cerebral Ventriculomegalies, Fetal,Cerebral Ventriculomegaly, Fetal,Fetal Cerebral Ventriculomegalies,Hydrocephalus Ex Vacuo,Hydrocephalus Ex-Vacuos,Hydrocephalus, Communicating,Hydrocephalus, Congenital,Hydrocephalus, Obstructive,Hydrocephalus, Post-Traumatic,Post Traumatic Hydrocephalus,Stenoses, Aqueductal,Stenosis, Aqueductal,Ventriculomegalies, Cerebral,Ventriculomegalies, Fetal Cerebral,Ventriculomegaly, Cerebral,Ventriculomegaly, Fetal Cerebral
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
November 1980, Psychiatrie, Neurologie, und medizinische Psychologie,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
May 1999, Nihon rinsho. Japanese journal of clinical medicine,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
March 2005, Nihon rinsho. Japanese journal of clinical medicine,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
October 1989, The Journal of pharmacology and experimental therapeutics,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
July 2018, Hypertension (Dallas, Tex. : 1979),
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
November 1988, Ceskoslovenska neurologie a neurochirurgie,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
May 1988, Ceskoslovenska neurologie a neurochirurgie,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
February 1997, Neuroscience letters,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
July 1966, Veterinariia,
N I Artiukhina, and K K Gekht, and O F Kuvaeva, and I P Levshina
October 1956, The Cornell veterinarian,
Copied contents to your clipboard!